Those who believe Relenza is in for a huge market of replenishing Pandemic stock of Tamiflu obviously is ignoring how hard GSK has been going around selling their Birdflu vaccine.
For those who took comfort in BTA's cash assets, read this in the article CPG posted: “Chairman Mal Eutick told BNW he had not expected the shares to be savaged so viciously yesterday. "The stock is trading well below its cash value," Dr Eutick said. Progen still has $76.7 million in its cash box, more than double its market cap of $35 million.”
When the management of a company shows how incompetent they are, that’s what happen to the sp!
BTA Price at posting:
0.0¢ Sentiment: Sell Disclosure: Not Held
